Gilead Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Gilead Sciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1% to $27,116,000,000. The net income raised on $5,665,000,000 and profit margin reached 21%. Total operating expenses were $13,013,000,000.

Profit Margin

Gilead Sciences, Inc. (NASDAQ:GILD): Profit margin
2014 24.89B 12.10B 48.62%
2015 32.63B 18.10B 55.48%
2016 30.39B 13.50B 44.43%
2017 26.10B 4.62B 17.73%
2018 22.12B 5.45B 24.65%
2019 22.44B 5.38B 23.99%
2020 24.68B 89M 0.36%
2021 27.30B 6.22B 22.8%
2022 27.28B 4.59B 16.83%
2023 27.11B 5.66B 20.89%

GILD Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
27.11B27.28B27.30B24.68B22.44B22.12B26.10B30.39B32.63B24.89B
Cost of revenue
6.49B5.65B6.60B4.57B4.67B4.85B4.37B4.26B4.00B3.78B
Gross profit
20.61B21.62B20.70B20.11B17.77B17.27B21.73B26.12B28.63B21.10B
Operating exp.
Research and development
6.92B4.97B5.36B5.03B9.10B5.01B3.73B5.09B3.01B2.85B
Selling and marketing
826M778M735M795M784M587M600M618M601M393M
Total operating expenses
13.01B10.65B10.60B10.19B13.48B9.07B7.61B8.49B6.44B5.83B
Operating income
7.60B7.33B7.40B7.02B4.28B8.2B14.12B17.63B22.19B15.26B
Other income (expenses), net
-746M-1.51B872M-2.40B873M676M-595M428M-534M-409M
Income before tax
6.85B5.81B8.27B1.66B5.16B7.79B13.52B17.09B21.65B14.85B
Income tax expense
1.24B1.24B2.07B1.58B-204M2.33B8.88B3.60B3.55B2.79B
Net income
5.66B4.59B6.22B89M5.38B5.45B4.62B13.50B18.10B12.10B
Earnings per share
Basic EPS
4.543.664.960.074.244.23.5410.0812.377.95
Diluted EPS
4.53.644.930.074.224.173.519.9411.917.35
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source